Jonathan Williams is an Infectious Disease physician affiliated with Henry Ford Health System. OpenAlex indexes 54 publications with 1,012 citations (h-index 12); ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2799 W Grand Blvd
Detroit, MI 482022608
Telephone
313-916-2600Provider last certified this registry record 28 May 2025.
Clinical trials
- Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
Sponsor: NYU Langone Health
- Dietary Biomarkers Intervention Core
Sponsor: Harvard School of Public Health (HSPH)
- The Role of Vasopressin Antagonism on Renal Sodium Handling
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20251 payment
- Astellas Pharma US IncProgram year20241 payment
- Astellas Pharma US IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
94.2%Protease Inhibitor17.8%Symtuza65%Prezcobix35%Part D<11 patientsFirst-generation cephalosporins15.7%Cefadroxil100%Part D<11 patients+ 5 more classes in this area
Respiratory
5.8%Leukotriene Receptor Antagonist5.8%Montelukast Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A playbook for harmonization of standards for emergent viral pathogens
Accreditation and Quality Assurance
2026 - Characterization of vaginal microbiomes in clinician-collected bacterial vaginosis diagnosed samples
Microbiology Spectrum
2025 - Improving Vaccination Rates in Adult Solid Organ Transplant Candidates: Impact of an Infectious Diseases Pretransplant Clinic
Transplant Infectious Disease
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Kalkanis, MD
Henry Ford Health System
Shirish Gadgeel, MD
Henry Ford Health System
Mani Menon, MD
Henry Ford Health System
Marcus Zervos, MD
Henry Ford Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”